Expert Advisor licence.

Licence and permitted use

This Expert Advisor licence agreement applies to ATAI software supplied by LUMINOVA AI TWIN INC. Read it together with the Terms of use, Risk Information and the requirements for your specific product.

The licence grants a limited, non-exclusive right to use the software within the term, account binding and usage limits stated for the product and your order. It does not transfer ownership of source code or other intellectual property. Do not share, resell, redistribute or bypass licence restrictions except where expressly permitted or required by applicable law. Free tools remain subject to their documented usage conditions; no purchase or licence key is required where the product page says so.

The software may be used on supported demo or live accounts, subject to its licence requirements, your broker’s rules and applicable law. Whether to use it with real money is your independent decision. This agreement does not impose a demo-only restriction.

Review the strategy and limitations, test the software on a demo account, and understand its behaviour before enabling live trading. You are responsible for deciding whether to use it, selecting the settings available to you, maintaining compatible systems and monitoring its operation. Disabling software or allowing a licence to expire may not close positions already open with your broker; follow the product guide and monitor your account directly.

Independent decisions and account control

ATAI provides software and general market information. ATAI does not hold your trading capital, exercise discretionary control over your brokerage account, or assess your personal financial circumstances to determine whether a product, strategy or trade is suitable for you.

You decide whether to act on a signal or install, enable, continue using or disable an Expert Advisor. Once enabled, an EA may automatically open, modify and close positions according to its programmed strategy without further approval for each order. You remain responsible for choosing that automation, understanding its documented limitations and monitoring your account. A tool that only supplies analysis or alerts does not execute trades merely because it is installed.

Acceptance of trading and operational risks

You acknowledge that trading outcomes are uncertain and accept the market risks associated with your trading decisions. These risks include adverse price movements, leverage, accumulated exposure, spread widening, slippage, gaps, commissions, financing costs and liquidation. Losses may include your entire trading capital and, where applicable, may exceed your deposit.

Software defects, delayed or rejected orders, inaccurate data, connection failures and interruptions involving terminals, brokers, VPS providers or licensing services may also affect operation. Risk controls, profit targets and stop orders cannot guarantee execution or prevent every loss.

A trading loss or an inaccurate forecast does not, by itself, establish that ATAI breached this agreement or that compensation is due. This does not prevent a customer from reporting a defect or exercising an applicable legal remedy.

Software availability and mandatory rights

To the extent permitted by applicable law, the software and services are supplied on an “as is” and “as available” basis. ATAI does not guarantee uninterrupted or error-free operation, compatibility with every broker or system, or any particular trading result.

Nothing in this agreement excludes mandatory consumer rights or liability that cannot lawfully be excluded. Acceptance of trading risk does not waive ATAI’s non-excludable legal obligations.

Support and remedies

Report activation problems or suspected defects to support@atai.ca with your order reference, software version and a description of the issue. Do not send passwords or wallet recovery phrases. We will review reported issues and applicable remedies under the cancellation and service-problems provisions. No immediate fix or uninterrupted service is promised; mandatory remedies remain available.